Immune myocarditis related to sintilimab treatment in a patient with advanced lung adenocarcinoma: A case report

Rare Case of Wide QRS Tachycardia After Sintilimab Treatment for Lung Cancer

(2022) Yi Tang et al.   CIRCULATION

Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor–induced Myocarditis

(2022) Farah Cadour et al.   RADIOLOGY

Sintilimab for the treatment of non-small cell lung cancer

(2022) Lin Zhang et al.   Biomarker Research

Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms

(2021) Javid Moslehi et al.   JOURNAL OF CLINICAL INVESTIGATION

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

(2021) Zhenggang Ren et al.   LANCET ONCOLOGY

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

(2021) Bryan J. Schneider et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review

(2021) Walid Shalata et al.   Cancers

Sintilimab-Induced Myocarditis Overlapping Myositis in a Patient With Metastatic Thymoma: A Case Report

(2021) Zi-xuan Yang et al.   Frontiers in Cardiovascular Medicine

Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma

(2020) Qian Xing et al.   Annals of Translational Medicine

Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure

(2020) Sarah Waliany et al.   Annual Review of Pharmacology and Toxicology

Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11)

(2020) Yunpeng Yang et al.   Journal of Thoracic Oncology

Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)

(2020) Si-Yang Liu et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Subclinical left ventricular dysfunction and correlation with regional strain analysis in myocarditis with normal ejection fraction. A new diagnostic criterion

(2018) Peggy M. Kostakou et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis

(2018) Javid J Moslehi et al.   LANCET